Source:http://linkedlifedata.com/resource/pubmed/id/21246528
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
2011-7-1
|
pubmed:abstractText |
Contemporary therapy for medulloblastoma results in adverse neurocognitive effects on young children, particularly those under the age of 3. Stratification of patients by risk group may allow toxic treatment to be avoided.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1097-0142
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 American Cancer Society.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
117
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3262-7
|
pubmed:dateRevised |
2011-9-26
|
pubmed:meshHeading |
pubmed-meshheading:21246528-Cerebellar Neoplasms,
pubmed-meshheading:21246528-Child, Preschool,
pubmed-meshheading:21246528-Combined Modality Therapy,
pubmed-meshheading:21246528-Female,
pubmed-meshheading:21246528-Humans,
pubmed-meshheading:21246528-Male,
pubmed-meshheading:21246528-Medulloblastoma,
pubmed-meshheading:21246528-Neoplasm Metastasis,
pubmed-meshheading:21246528-Prognosis
|
pubmed:year |
2011
|
pubmed:articleTitle |
Histology predicts a favorable outcome in young children with desmoplastic medulloblastoma: a report from the children's oncology group.
|
pubmed:affiliation |
Division of Hematology/Oncology, Seattle Children's, Seattle, Washington, USA. sarah.leary@seattlechildrens.org
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|